Wharton’s Jelly-Derived Mesenchymal Stem Cell Transplantation in a Patient with Hypoxic-Ischemic Encephalopathy

Wharton’s Jelly-Derived Mesenchymal Stem Cell Transplantation in a Patient with Hypoxic-Ischemic Encephalopathy

Wharton’s jelly-derived mesenchymal stem cells (WJ-MSCs) have been introduced as a possible therapy in hypoxic-ischemic encephalopathy (HIE). We report a 16-year-old boy who was treated with WJ-MSCs in the course of HIE due to post-cardiopulmonary resuscitation. He received a long period of mechanic...

Full description

Bibliographic Details
Main Authors: Serdar Kabataş, Erdinç Civelek, Çiğdem İnci, Ebru Yılmaz Yalçınkaya, Gülşen Günel, Gülay Kır, Esra Albayrak, Erek Öztürk, Gökhan Adaş, Erdal Karaöz
Format: Article
Language:English
Published: SAGE Publishing 2018-10-01
Series:Cell Transplantation
Online Access:https://doi.org/10.1177/0963689718786692

Similar Items

Similar Items